RIBOMAB
BioNTech RNA Pharmaceuticals GmbH
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79218814 |
| Registration Number | 5510495 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | N40 |
| Employee Name | BLAZICH, JOAN MICHELE |
Timeline
| 2017-08-22 | Application Filed |
| 2018-04-24 | Published for Opposition |
| 2018-07-10 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-07-10 | Status: Live/Registered |
| 2018-07-10 | Trademark Registered |
| 2018-10-22 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BioNTech RNA Pharmaceuticals GmbH |
| Address | An der Goldgrube 12 55131 Mainz DE |
| Legal Entity Type | Gesellschaft Mit Beschränkter Haftung (gmbh) |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals and veterinary preparations, of all kinds, namely, pharmaceuticals and veterinary preparations for treating cancerous diseases, infections, autoimmune disorders and metabolic disorders; diagnostic preparations for the detection of cancerous diseases, infections, autoimmune disorders and metabolic disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2017-10-19 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-10-23 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2017-10-27 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2017-11-27 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-12-04 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2017-12-05 | 6 RFCR E:E-Mail |
| NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | 2017-12-14 | 7 RFWR P: |
| NON-FINAL ACTION WRITTEN | 2017-12-18 | 8 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2017-12-19 | 9 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2018-01-08 | 10 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2018-01-08 | 11 RFCS P: |
| REFUSAL PROCESSED BY IB | 2018-01-27 | 12 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-02-26 | 13 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2018-03-09 | 14 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-03-13 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-03-13 | 16 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-20 | 17 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2018-04-04 | 18 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2018-04-24 | 19 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2018-07-10 | 20 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2018-10-10 | 21 FICR P: |
| FINAL DISPOSITION PROCESSED | 2018-10-22 | 22 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2018-10-22 | 23 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2018-11-09 | 24 FINO P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2021-12-31 | 25 CHLD M: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-04-15 | 26 NREP P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 